Krebs Biochemicals & Industries Limited (BOM:524518)
India flag India · Delayed Price · Currency is INR
55.88
-0.28 (-0.50%)
At close: Nov 6, 2026

BOM:524518 Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
1.261.291.421.370.861.01
Cash & Short-Term Investments
1.261.291.421.370.861.01
Cash Growth
-0.94%-8.83%3.06%60.14%-14.71%-85.84%
Accounts Receivable
0.040.040.547.276.518.77
Other Receivables
-1.621.741.671.360.97
Receivables
0.041.662.2448.957.879.73
Inventory
42.2663.6765.98102.45123.56258.65
Prepaid Expenses
-3.544.733.765.184.93
Other Current Assets
34.7226.0628.2217.923.1480.62
Total Current Assets
78.2896.22102.59174.42160.61354.93
Property, Plant & Equipment
1,4081,4301,4651,4951,4871,442
Other Intangible Assets
--18.4718.4718.4718.47
Long-Term Deferred Charges
1.962.884.726.568.410.24
Other Long-Term Assets
99.55103.2999.8487.7375.2272.26
Total Assets
1,5881,6321,6901,7821,7501,898

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
124.47137.58181.53189.7152.81395.47
Accrued Expenses
8.24220.69167.94128.6195.29119.75
Short-Term Debt
724.86612.88509.5899.399.999.86
Current Portion of Long-Term Debt
---2.471.341.83
Other Current Liabilities
402.48159.51176.21198.27141.71163.73
Total Current Liabilities
1,2601,1311,035618.34491.05780.64
Long-Term Debt
1,5451,6361,6131,8351,7321,329
Pension & Post-Retirement Benefits
-24.8427.6825.5622.923.32
Other Long-Term Liabilities
489.13469.02477.3495.01498.03515.73
Total Liabilities
3,2943,2603,1532,9742,7442,649

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
215.61215.61215.61215.61215.61215.61
Additional Paid-In Capital
-1,1801,1801,1801,1801,180
Retained Earnings
--3,138-2,973-2,702-2,505-2,261
Comprehensive Income & Other
-1,922114.45114.45114.45114.45114.45
Shareholders' Equity
-1,706-1,628-1,462-1,192-994.62-750.93
Total Liabilities & Equity
1,5881,6321,6901,7821,7501,898

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
2,2702,2482,1221,9371,8341,431
Net Cash (Debt)
-2,269-2,247-2,121-1,935-1,833-1,430
Net Cash Growth
------
Net Cash Per Share
-105.26-104.22-98.36-89.77-85.01-66.32
Filing Date Shares Outstanding
21.5921.5621.5621.5621.5621.56
Total Common Shares Outstanding
21.5921.5621.5621.5621.5621.56
Working Capital
-1,182-1,034-932.67-443.92-330.44-425.71
Book Value Per Share
-79.02-75.49-67.83-55.29-46.13-34.83
Tangible Book Value
-1,706-1,628-1,481-1,211-1,013-769.4
Tangible Book Value Per Share
-79.02-75.49-68.68-56.15-46.99-35.69
Land
-484.19484.19484.19484.19484.19
Buildings
-275.47275273.02266.37256.92
Machinery
-2,3482,3502,3352,2482,106
Construction In Progress
-15.8712.41.5622.4365.31